Protecting Indian schoolchildren against rabies. Pre-exposure vaccination with purified chick embryo cell vaccine (PCECV) or purified verocell rabies vaccine (PVRV)

Human Vaccines

Volumn 4, Issue 5, 2008, Pages 365-369

  Shanbag, Preeti ^a   Shah, Nitin ^b   Kulkarni, Madhuri ^a   Juvekar, Manisha ^a   Madhusudana, S N ^c   Vakil, Hoshang B ^d   Malerczyk, Claudius ^e  

^a Lokmanya Tilak Medical College   (India)

^b P D HINDUJA NATIONAL HOSPITAL   (India)

^c NATIONAL INSTITUTE OF MENTAL HEALTH AND NEUROSCIENCES   (India)

^d Novartis Vaccines and Diagnostics   (India)

^e Global Medical Affairs   (Germany)

Author keywords

PCECV; Pre exposure prophylaxis; PVRV; Rabies; Schoolchildren

Indexed keywords

NEUTRALIZING ANTIBODY; RABIES VACCINE; VIRUS ANTIBODY;

ADOLESCENT; ANTIBODY DETECTION; ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG FEVER; DRUG HYPERSENSITIVITY; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG SOLUBILITY; DRUG TOLERABILITY; ERYTHEMA; FEMALE; HUMAN; IMMUNE RESPONSE; IMMUNOGENICITY; INDIA; INDIAN; INJECTION SITE PAIN; IRRITABILITY; MALAISE; MALE; MYALGIA; PAIN ASSESSMENT; RABIES; RABIES VIRUS; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SKIN INDURATION; SWELLING; VISUAL ANALOG SCALE;

EID: 54949148728     PISSN: 15548600     EISSN: 15548619     Source Type: Journal    
DOI: 10.4161/hv.4.5.5987     Document Type: Article

References (34)

1. Knobel DL, Cleaveland S, Coleman PG, Fèvre EM, Meltzer MI, Miranda MEG, et al. Re-evaluating the burden of rabies in Africa and Asia. Bull World Health Organ 2005; 83:360-8.
2. Sudarshan MK, Madhusudana SN, Mahendra BJ, Rao NS, Ashwath Narayana DH, Abdul RS, et al. Assessing the burden of human rabies in India: results of a national multi-center epidemiological survey. Int J Infect Dis 2007; 11:29-35.
3. Eng TR, Fishbein DB, Talamante HE, Hall DB, Chavez GF, Dobbins JG, et al. Urban epizootic of rabies in Mexico: epidemiology and impact of animal bite injuries. Bull World Health Organ 1993; 71:615-24.
4. Thongcharoen P, Wasi C, Sirikawin S, Chaiprasithikul P, Puthavathana P. Rabies and post-exposure prophylaxis in Thai children. Asian Pac J Allergy Immunol 1989; 7:41-6.
5. WHO. WER 2001 - Rabies Asia. Wkly Epidemiol Rec 2001; 76:319-20.
6. Wilde H, Briggs DJ, Meslin FX, Hemachudha T, Sitprija V. Rabies update for travel medicine advisors. Clin Infect Dis 2003; 37:96-100.
7. Sriaroon C, Sriaroon P, Daviratanasilpa S, Khawplod P, Wilde H. Retrospective: animal attacks and rabies exposures in Thai children. Travel Med Infect Dis 2006; 4:270-4.
8. WHO. WHO Expert Consultation on Rabies: first report. Geneva, Switzerland: WHO; 2004. Report No.:931.
9. Bahri F, Letaief A, Ernez M, Elouni J, Chekir T, Ben Ammou S, Jemni L. Neurological complications in adults following rabies vaccine prepared from animal brains. Presse Med 1996; 25:491-3.
10. Swaddiwudhipong W, Prayoonwiwat N, Kunasol P, Choomkasien P. A high incidence of neurological complications following Semple anti-rabies vaccine. Southeast Asian J Trop Med Public Health 1987; 18:526-31.
11. Ichhpujani RL. Rabies in India; in: Dodet B, Meslin FX, Heseltine E, editors. 4th International Symposium on Rabies Control in Asia, Hanoi, Vietnam, 5-9 March 2001, WHO/Fondation Mérieux, John Libbey Eurotext.
12. Wilde H, Sirikawin S, Sabchareon A, Kingnate D, Tantawichien T, Harischandra PAL, Chaiyabutr N, de Silva DGH, Fernando L, Liyanage JB, Sitprija V. Failure of postexposure treatment of rabies in children. Clin Infect Dis 1996; 22:228-32.
13. Hemachudha T, Mitrabhakdi E, Wilde H, Vejabhuti A, Siripataravanit S, Kingnate D. Additional reports of failure to respond to treatment after rabies exposure in Thailand. Clin Infect Dis 1999; 28:143-4.
14. Arya SC. Failures of postexposure rabies and other immmunotherapies in developing countries. Vaccine 1989; 7:372.
15. Sriaroon C, Daviratanasilpa S, Sansomranjai P, Khawplod P, Hemachudha T, Khamoltham T, Wilde H. Rabies in a Thai child treated with the eight-site post-exposure regimen without rabies immune globulin. Vaccine 2003; 21:3525-6.
16. Wilde H, Choomkasien P, Hemachudha T, Supich C, Chutivongse S. Failure of rabies postexposure treatment in Thailand. Vaccine 1989; 7:49-52.
17. Gacouin A, Bourhy H, Renaud JC, Camus C, Suprin E, Thomas R. Human rabies despite postexposure vaccination. Eur J Clin Microbiol Infect Dis 1999; 18:233-5.
18. Briggs DJ, Dreesen DW, Nicolay U, Chin JE, Davis R, Gordon C, Banzhoff A. Purified Chick Embryo Cell Culture Rabies Vaccine: interchangeability with Human Diploid Cell Culture Rabies Vaccine and comparison of one versus two-dose post-exposure booster regimen for previously immunized persons. Vaccine 2000; 19:1055-60.
19. Jaiiaroensup W, Lang J, Thipkong P, Wimalaratne O, Samranwataya P, Saikasem A, Chareonwai S, Yenmuang W, Pakongsri S, Sitprija V, Wilde H. Safety and efficacy of purified Vero cell rabies vaccine given intramuscularly and intradermally. (Results of a prospective randomized trial). Vaccine 1998; 16:1559-62.
20. Lang J, Hoa DQ, Gioi NV, Tho LT, Vien NC, Nguyen CV, Rouyrre N, Forrat R. Immunogenicity and safety of low-dose intradermal rabies vaccination given during an Expanded Programme on Immunization session in Viet Nam: results of a comparative randomized trial. Trans R Soc Trop Med Hyg 1999; 93:208-13.
21. Lang J, Rongrre N, Plotkin S, Hoa DQ, Gioi NV, Le TT. Booster vaccination at 1 year with a rabies vaccine associated with DTP-1PV in infants living in a rabies endemic country. J Trop Pediatr 1999; 45:181-3.
22. Malerczyk C, Briggs DJ, Dreesen DW, Banzhoff A. Duration of immunity: an anamnestic response 14 years after rabies vaccination with purified chick embryo cell rabies vaccine. J Travel Med 2007; 14:63-4.
23. Nicholson KG, Farrow PR, Bijok U, Barth R. Pre-exposure studies with purified chick embryo cell culture rabies vaccine and human diploid cell vaccine: serological and clinical responses in man. Vaccine 1987; 5:208-10.
24. Pengsaa K, Limkittikul K, Ariyasriwarana C, Chanthavichc P, Attanath P, Malerczyk C, Sabchareon A. Immunogenicity and safety of pre-exposure IM and ID regimens of purified chick embryo cell rabies vaccine administered concomitantly with Japanese Encephalitis vaccine in toddlers. 2nd Asian Congress of Pediatric Infectious Diseases: Kota Kinabalu. Malaysia, September 2-4th, 2004; abstract no. FPS2-2.
25. Sabchareon A, Chantavanich P, Pasuralertsakul S, Pojjaroen-Anant C, Prarinyanupharb V, Attanath P, et al. Persistence of antibodies in children after intradermal or intramuscular administration of preexposure primary and booster immunizations with purified Vero cell rabies vaccine. Pediatr Infect Dis J 1998; 17:1001-7.
26. Kamoltham T, Thinyounyong W, Phongchamnaphai P, Phraisuwan P, Khawplod P, Banzhoff A, Malerczyk C. Pre-exposure rabies vaccination of children in Thailand using Purified Chick Embryo Cell Rabies Vaccine intradermally is immunogenic and safe. J Ped 2007; 151:173-7.
27. Kulkarni R, Thatte U, Shinde V, Dharadhar S, Popova O, Vakil H. A comparison of the tolerability of two dilution volumes (0.5 mL and 1.0 mL) of a purified chick embryo cell rabies vaccine administered intramuscularly to healthy adult volunteers: a randomized, individual, assessor-blind study. Current Therapeutic Research 2004; 65:47-56.
28. Nony P, Girard P, Chabaud S, Hessel L, Thébault C, Boissel JP. Impact of osmolality on burning sensations during and immediately after intramuscular injection of 0.5 ml of vaccine suspensions in healthy subjects. Vaccine 2001; 19:3645-51.
29. Diggle L, Deeks JJ. Effect of needle length on incidence of local reactions to routine immunisation in infants aged 4 months: randomised controlled trial, BMJ 2000; 321:931-3.
30. Diggle L, Deeks JJ, Pollard AJ. Effect of needle size on immunogenicity and reactogenicity of vaccines in infants: randomised controlled trial. BMJ 2006; 333:571.
31. Cook IF, Murtagh J. Optimal technique for intramuscular injection of infants and toddlers: a randomized trial. Med J Aust 2005; 183:60-3.
32. Wiesenthal AM, Lauer BA. Syringe preparation technique and minor adverse reactions to diphtheria-tetanus-pertussis immunization. Pediatr Infect Dis 1987; 6:1048-50.
33. Salomon ME, Halperin R, Yee J. Evaluation of the two-needle strategy for reducing reactions to DPT vaccination. Am J Dis Child 1987; 141:796-8.
34. Smith JS, Yager P, Baer GM. A rapid flourescent focus inhibition test (RFFIT) for determining rabies virus-neutralizing antibody. In: Meslin FX, Kaplan MM, Koprowski H, editors. Laboratory techniques in rabies. 4th ed. Geneva: WHO; 1996; 181-91.